Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2020

Open Access 01-12-2020 | Hemophilia | Research article

In vivo fluorescence molecular tomography of induced haemarthrosis in haemophilic mice: link between bleeding characteristics and development of bone pathology

Authors: K. K. Vøls, M. Kjelgaard-Hansen, C. D. Ley, A. K. Hansen, M. Petersen

Published in: BMC Musculoskeletal Disorders | Issue 1/2020

Login to get access

Abstract

Background

Haemophilic arthropathy is a chronic and debilitating joint disease caused by recurrent spontaneous joint bleeds in patients with haemophilia. Understanding how characteristics of individual joint bleeds relate to the subsequent development of arthropathy could improve management and prevention of this joint disease. Here, we aimed to explore relations between joint bleed characteristics and development of bone pathology in a mouse model of haemophilic arthropathy by using novel in vivo imaging methodology.

Methods

We characterised induced knee bleeds in a murine model of haemophilic arthropathy by quantitative in vivo fluorescence molecular tomography (FMT) and by measurements of changes in the diameter of the injured knee. Wild-type mice and non-injured haemophilic mice acted as controls. Development of arthropathy was characterised by post mortem evaluation of bone pathology by micro-CT 14 days after bleed-induction. In an in vitro study, we assessed the effect of blood on the quantification of fluorescent signal with FMT.

Results

In most injured haemophilic mice, we observed significant loss of trabecular bone, and half of the mice developed pathological bone remodelling. Development of pathological bone remodelling was associated with significantly increased fluorescent signal and diameter of the injured knee just 1 day after induction of the bleed. Further, a correlation between the fluorescent signal 1 day after induction of the bleed and loss of trabecular bone reached borderline significance. In the in vitro study, we found that high concentrations of blood significantly decreased the fluorescent signal.

Conclusion

Our results add novel insights on the pathogenesis of haemophilic arthropathy and underline the importance of the acute phase of joint bleeds for the subsequent development of arthropathy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mannucci PM, Tuddenham EG. The hemophilias--from royal genes to gene therapy. N Engl J Med. 2001;344(23):1773–9.PubMedCrossRef Mannucci PM, Tuddenham EG. The hemophilias--from royal genes to gene therapy. N Engl J Med. 2001;344(23):1773–9.PubMedCrossRef
2.
6.
go back to reference Kidder W, et al. Persistent vascular remodeling and leakiness are important components of the pathobiology of re-bleeding in hemophilic joints: two informative cases. Microcirculation. 2016;23(5):373–8.PubMedCrossRef Kidder W, et al. Persistent vascular remodeling and leakiness are important components of the pathobiology of re-bleeding in hemophilic joints: two informative cases. Microcirculation. 2016;23(5):373–8.PubMedCrossRef
7.
go back to reference Ghosh K, Shetty S. Bone health in persons with haemophilia: a review. Eur J Haematol. 2012;89(2):95–102.PubMedCrossRef Ghosh K, Shetty S. Bone health in persons with haemophilia: a review. Eur J Haematol. 2012;89(2):95–102.PubMedCrossRef
8.
go back to reference Jansen NW, Roosendaal G, Lafeber FP. Understanding haemophilic arthropathy: an exploration of current open issues. Br J Haematol. 2008;143(5):632–40.PubMedCrossRef Jansen NW, Roosendaal G, Lafeber FP. Understanding haemophilic arthropathy: an exploration of current open issues. Br J Haematol. 2008;143(5):632–40.PubMedCrossRef
9.
go back to reference Raffini L, Manno C. Modern management of haemophilic arthropathy. Br J Haematol. 2007;136(6):777–87.PubMedCrossRef Raffini L, Manno C. Modern management of haemophilic arthropathy. Br J Haematol. 2007;136(6):777–87.PubMedCrossRef
10.
go back to reference Fischer K, et al. Association between joint bleeds and Pettersson scores in severe haemophilia. Acta Radiol. 2002;43(5):528–32.PubMedCrossRef Fischer K, et al. Association between joint bleeds and Pettersson scores in severe haemophilia. Acta Radiol. 2002;43(5):528–32.PubMedCrossRef
11.
go back to reference Aledort LM, Haschmeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic outcome study group. J Intern Med. 1994;236(4):391–9.PubMedCrossRef Aledort LM, Haschmeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic outcome study group. J Intern Med. 1994;236(4):391–9.PubMedCrossRef
12.
go back to reference Manco-Johnson MJ, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357(6):535–44.PubMedCrossRef Manco-Johnson MJ, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357(6):535–44.PubMedCrossRef
13.
go back to reference Manco-Johnson MJ, et al. Results of secondary prophylaxis in children with severe hemophilia. Am J Hematol. 1994;47(2):113–7.PubMedCrossRef Manco-Johnson MJ, et al. Results of secondary prophylaxis in children with severe hemophilia. Am J Hematol. 1994;47(2):113–7.PubMedCrossRef
14.
go back to reference van Vulpen LFD, et al. Differential effects of bleeds on the development of arthropathy - basic and applied issues. Haemophilia. 2017;23(4):521–7..PubMedCrossRef van Vulpen LFD, et al. Differential effects of bleeds on the development of arthropathy - basic and applied issues. Haemophilia. 2017;23(4):521–7..PubMedCrossRef
15.
go back to reference Øvlisen K, Kristensen AT, Tranholm M. In vivo models of haemophilia - status on current knowledge of clinical phenotypes and therapeutic interventions. Haemophilia. 2008;14(2):248–59.PubMedCrossRef Øvlisen K, Kristensen AT, Tranholm M. In vivo models of haemophilia - status on current knowledge of clinical phenotypes and therapeutic interventions. Haemophilia. 2008;14(2):248–59.PubMedCrossRef
16.
go back to reference Valentino LA, et al. Experimental haemophilic synovitis: rationale and development of a murine model of human factor VIII deficiency. Haemophilia. 2004;10(3):280–7.PubMedCrossRef Valentino LA, et al. Experimental haemophilic synovitis: rationale and development of a murine model of human factor VIII deficiency. Haemophilia. 2004;10(3):280–7.PubMedCrossRef
17.
go back to reference Cooke EJ, et al. Vascular permeability and Remodelling coincide with inflammatory and reparative processes after joint bleeding in factor VIII-deficient mice. Thromb Haemost. 2018;118(6):1036–47.PubMedPubMedCentralCrossRef Cooke EJ, et al. Vascular permeability and Remodelling coincide with inflammatory and reparative processes after joint bleeding in factor VIII-deficient mice. Thromb Haemost. 2018;118(6):1036–47.PubMedPubMedCentralCrossRef
18.
go back to reference Christensen KR, et al. Visualization of haemophilic arthropathy in F8(−/−) rats by ultrasonography and micro-computed tomography. Haemophilia. 2016;23(1):152–62.PubMedCrossRef Christensen KR, et al. Visualization of haemophilic arthropathy in F8(−/−) rats by ultrasonography and micro-computed tomography. Haemophilia. 2016;23(1):152–62.PubMedCrossRef
19.
go back to reference Vøls KK, et al. Bleed volume of experimental knee haemarthrosis correlates with the subsequent degree of haemophilic arthropathy. Haemophilia. 2019;25(2):324–33.PubMedCrossRef Vøls KK, et al. Bleed volume of experimental knee haemarthrosis correlates with the subsequent degree of haemophilic arthropathy. Haemophilia. 2019;25(2):324–33.PubMedCrossRef
20.
go back to reference Gompels LL, et al. In vivo optical imaging in arthritis--an enlightening future? Rheumatology (Oxford). 2010;49(8):1436–46.CrossRef Gompels LL, et al. In vivo optical imaging in arthritis--an enlightening future? Rheumatology (Oxford). 2010;49(8):1436–46.CrossRef
21.
go back to reference Slooter MD, et al. Near infrared fluorescence imaging for early detection, monitoring and improved intervention of diseases involving the joint. Connect Tissue Res. 2015;56(2):153–60.PubMedCrossRef Slooter MD, et al. Near infrared fluorescence imaging for early detection, monitoring and improved intervention of diseases involving the joint. Connect Tissue Res. 2015;56(2):153–60.PubMedCrossRef
22.
go back to reference Ntziachristos V, et al. Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol. 2005;23(3):313–20.PubMedCrossRef Ntziachristos V, et al. Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol. 2005;23(3):313–20.PubMedCrossRef
24.
go back to reference Rosenhain S, et al. Sensitivity and accuracy of hybrid fluorescence-mediated tomography in deep tissue regions. J Biophotonics. 2017;10(9):1208–16.PubMedCrossRef Rosenhain S, et al. Sensitivity and accuracy of hybrid fluorescence-mediated tomography in deep tissue regions. J Biophotonics. 2017;10(9):1208–16.PubMedCrossRef
25.
go back to reference Groth M, et al. Buprenorphine does not impact the inflammatory response in haemophilia a mice with experimentally-induced haemarthrosis. Lab Anim. 2014;48(3):225–36.PubMedCrossRef Groth M, et al. Buprenorphine does not impact the inflammatory response in haemophilia a mice with experimentally-induced haemarthrosis. Lab Anim. 2014;48(3):225–36.PubMedCrossRef
26.
go back to reference Montet X, et al. Tomographic fluorescence imaging of tumor vascular volume in mice. Radiology. 2007;242(3):751–8.PubMedCrossRef Montet X, et al. Tomographic fluorescence imaging of tumor vascular volume in mice. Radiology. 2007;242(3):751–8.PubMedCrossRef
27.
go back to reference Valentino LA, et al. The biological efficacy profile of BAX 855, a PEGylated recombinant factor VIII molecule. Haemophilia. 2015;21(1):58–63.PubMedCrossRef Valentino LA, et al. The biological efficacy profile of BAX 855, a PEGylated recombinant factor VIII molecule. Haemophilia. 2015;21(1):58–63.PubMedCrossRef
28.
go back to reference Lau AG, et al. Joint bleeding in factor VIII deficient mice causes an acute loss of trabecular bone and calcification of joint soft tissues which is prevented with aggressive factor replacement. Haemophilia. 2014;20(5):716–22.PubMedPubMedCentralCrossRef Lau AG, et al. Joint bleeding in factor VIII deficient mice causes an acute loss of trabecular bone and calcification of joint soft tissues which is prevented with aggressive factor replacement. Haemophilia. 2014;20(5):716–22.PubMedPubMedCentralCrossRef
30.
go back to reference Haller J, et al. Visualization of pulmonary inflammation using noninvasive fluorescence molecular imaging. J Appl Physiol (1985). 2008;104(3):795–802.CrossRef Haller J, et al. Visualization of pulmonary inflammation using noninvasive fluorescence molecular imaging. J Appl Physiol (1985). 2008;104(3):795–802.CrossRef
32.
33.
go back to reference Persigehl T, et al. Non-invasive monitoring of tumor-vessel infarction by retargeted truncated tissue factor tTF-NGR using multi-modal imaging. Angiogenesis. 2014;17(1):235–46.PubMedCrossRef Persigehl T, et al. Non-invasive monitoring of tumor-vessel infarction by retargeted truncated tissue factor tTF-NGR using multi-modal imaging. Angiogenesis. 2014;17(1):235–46.PubMedCrossRef
34.
go back to reference Gremse F, et al. Absorption reconstruction improves biodistribution assessment of fluorescent nanoprobes using hybrid fluorescence-mediated tomography. Theranostics. 2014;4(10):960–71.PubMedPubMedCentralCrossRef Gremse F, et al. Absorption reconstruction improves biodistribution assessment of fluorescent nanoprobes using hybrid fluorescence-mediated tomography. Theranostics. 2014;4(10):960–71.PubMedPubMedCentralCrossRef
35.
go back to reference Ntziachristos V, et al. Fluorescence molecular tomography resolves protease activity in vivo. Nat Med. 2002;8(7):757–60.PubMedCrossRef Ntziachristos V, et al. Fluorescence molecular tomography resolves protease activity in vivo. Nat Med. 2002;8(7):757–60.PubMedCrossRef
36.
go back to reference He P, et al. Timely and large dose of clotting factor IX provides better joint wound healing after hemarthrosis in hemophilia B mice. Int J Hematol. 2019;110(1):59–68.PubMedCrossRef He P, et al. Timely and large dose of clotting factor IX provides better joint wound healing after hemarthrosis in hemophilia B mice. Int J Hematol. 2019;110(1):59–68.PubMedCrossRef
37.
go back to reference Mackie EJ, et al. Protease-activated receptors in the musculoskeletal system. Int J Biochem Cell Biol. 2008;40(6–7):1169–84.PubMedCrossRef Mackie EJ, et al. Protease-activated receptors in the musculoskeletal system. Int J Biochem Cell Biol. 2008;40(6–7):1169–84.PubMedCrossRef
38.
go back to reference Christensen KR, et al. Rapid inflammation and early degeneration of bone and cartilage revealed in a time-course study of induced haemarthrosis in haemophilic rats. Rheumatology (Oxford). 2019;58(4):588–99.CrossRef Christensen KR, et al. Rapid inflammation and early degeneration of bone and cartilage revealed in a time-course study of induced haemarthrosis in haemophilic rats. Rheumatology (Oxford). 2019;58(4):588–99.CrossRef
39.
go back to reference Wallny TA, et al. Osteoporosis in haemophilia - an underestimated comorbidity? Haemophilia. 2007;13(1):79–84.PubMedCrossRef Wallny TA, et al. Osteoporosis in haemophilia - an underestimated comorbidity? Haemophilia. 2007;13(1):79–84.PubMedCrossRef
40.
go back to reference Gerstner G, et al. Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia. Haemophilia. 2009;15(2):559–65.PubMedCrossRef Gerstner G, et al. Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia. Haemophilia. 2009;15(2):559–65.PubMedCrossRef
41.
go back to reference Haxaire C, et al. Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathway. Blood. 2018;132(10):1064–74.PubMedPubMedCentralCrossRef Haxaire C, et al. Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathway. Blood. 2018;132(10):1064–74.PubMedPubMedCentralCrossRef
42.
go back to reference Azuma Y, et al. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem. 2000;275(7):4858–64.PubMedCrossRef Azuma Y, et al. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem. 2000;275(7):4858–64.PubMedCrossRef
Metadata
Title
In vivo fluorescence molecular tomography of induced haemarthrosis in haemophilic mice: link between bleeding characteristics and development of bone pathology
Authors
K. K. Vøls
M. Kjelgaard-Hansen
C. D. Ley
A. K. Hansen
M. Petersen
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2020
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-020-03267-5

Other articles of this Issue 1/2020

BMC Musculoskeletal Disorders 1/2020 Go to the issue